(64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
- Published In:
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 48(7), 1162-71 (2007)
- Authors:
- Li, Zi-Bo, Cai, Weibo, Cao, Qizhen, Chen, Kai, Wu, Zhanhong, He, Lina, Chen, Xiaoyuan
- Database ID:
- RPEP-01259
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01259APA
Li, Zi-Bo; Cai, Weibo; Cao, Qizhen; Chen, Kai; Wu, Zhanhong; He, Lina; Chen, Xiaoyuan. (2007). (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 48(7), 1162-71.
MLA
Li, Zi-Bo, et al. "(64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.." Journal of nuclear medicine : official publication, 2007.
RethinkPeptides
RethinkPeptides Research Database. "(64)Cu-labeled tetrameric and octameric RGD peptides for sma..." RPEP-01259. Retrieved from https://rethinkpeptides.com/research/li-2007-64culabeled-tetrameric-and-octameric
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.